Background Cervical cancer can be prevented by early detection and treatment for
precancerous lesions. Since 1995, there has been a national cervical cancer screening …

We developed metadta, a flexible, robust, and user‐friendly statistical procedure that fuses
established and innovative statistical methods for meta‐analysis, meta‐regression, and …

Simple Summary Human papillomaviruses (HPV) are common sexually transmitted
infections and they are responsible for cervical cancer (CC), as well as for several other …

Background In 2017, the Dutch cervical cancer screening program had replaced the primary
cytology-based screening with primary high-risk human papillomavirus-based screening …

Abstract Background The VALidation of HPV GENoyping Tests (VALGENT) is an
international initiative designed to validate HPV assays with genotyping capability. The …

Evidence-based clinical guidelines ensure best practice protocols are available in health
care. There is a widespread use of human papillomavirus deoxyribonucleic acid (HPV-DNA) …

Objectives To describe the methods used to quantify heterogeneity and to propose
alternative measures to improve reporting of heterogeneity in Cochrane diagnostic test …

Background Primary human papillomavirus (HPV) cervical screening is due to be
implemented in England within the next 2 years; however, the acceptability of HPV testing as …

Background: Cervical intraepithelial neoplasia (CIN) is a precancerous condition that, if
progresses, can cause cervical cancer. Less severe forms such as CIN1 regress …

Background To investigate distributions of cervical lesions and factors associated with the
severity of the cervical lesions in high-risk HPV (hr-HPV) positive women with atypical …